Related Experiment Video
Updated: Jul 16, 2026
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Published on: July 8, 2011
[Inhibitory effects of RNA interference on MyD88 expression and biological activity in murine myeloid dendritic
Jia-Jun Chen1, Zong-Quan Sun, Nian-Guo Dong
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. cjj329@163.com
Aim:
To investigate inhibitory effects of RNA interference on MyD88 expression in murine myeloid dendritic cells(DCs) and detect the biological activity of DCs.
Methods:
Three pairs of myeloid differentiation factor 88(MyD88) siRNA were synthesized and transfected into DCs by RNAi-mate. The mRNA and protein expression of MyD88 were analyzed by semi-quantified RT-PCR and Western blot. Mouse DCs were divided into control group and RNA interference group. One of the highest effective siRNA was transfected into RNA interference group. 12 hours later, LPS of the final concentrations of 1.0 mg/L was added in two groups and continued to culture for 3 days. The phenotype and functional properties of DCs were detected by flow cytometry and mixed lymphocyte reaction (MLR). The concentration of TNF-alpha, IFN-gamma and IL-12 in the supernatant was detected by ELISA, and the concentration of NF-kappaB was detected by immunochemistry.
Results:
mRNA and protein expression were reduced 90% and 85% in sequence2 siRNA, 92% and 88% in sequence3 siRNA respectively but no change was found in other groups. LPS stimulation increased the expression of CD80, CD86 and MHC-II in the cytomembrane of DCs, the concentration of TNF-alpha, IFN-gamma and IL-12 in the supernatant in control group. Besides, LPS stimulation promoted the shift of NF-kappaB to karyon and the proliferation of allogeneic T cells in control group. RNA interference inhibited these effects induced by LPS.
Conclusion:
RNA interference can reduce MyD88 expression in murine myeloid dendritic cells and inhibit the maturation of DCs, which may provide a new strategy of gene therapy for related diseases.
Insights
RNA interference effectively reduces myeloid differentiation factor 88 (MyD88) expression in dendritic cells (DCs). This inhibition suppresses DC maturation and biological activity, offering a potential gene therapy strategy.
Area of Science:
- Immunology
- Molecular Biology
- Gene Therapy
Background:
- Dendritic cells (DCs) play a crucial role in immune responses.
- Myeloid differentiation factor 88 (MyD88) is a key adaptor protein in Toll-like receptor signaling pathways, influencing DC maturation and function.
- Understanding MyD88's role is vital for developing targeted immunotherapies.
Purpose of the Study:
- To investigate the efficacy of RNA interference (RNAi) in suppressing MyD88 expression in murine myeloid dendritic cells (DCs).
- To evaluate the impact of MyD88 knockdown on DC biological activity, including phenotype and function.
- To explore the potential of RNAi-mediated MyD88 inhibition as a therapeutic strategy.
Main Methods:
- Synthesis and transfection of MyD88-specific small interfering RNA (siRNA) into murine DCs.
- Semi-quantitative RT-PCR and Western blot analysis to confirm MyD88 mRNA and protein downregulation.
- Flow cytometry and mixed lymphocyte reaction (MLR) to assess DC phenotype and allogeneic T cell proliferation.
- ELISA and immunochemistry to measure cytokine levels (TNF-alpha, IFN-gamma, IL-12) and NF-kappaB translocation.
Main Results:
- Specific siRNA sequences significantly reduced MyD88 mRNA and protein levels by over 90% and 85%, respectively.
- Lipopolysaccharide (LPS) stimulation enhanced DC maturation markers (CD80, CD86, MHC-II) and pro-inflammatory cytokine production in control DCs.
- RNA interference targeting MyD88 effectively inhibited LPS-induced DC maturation, cytokine release, NF-kappaB activation, and T cell proliferation.
Conclusions:
- RNA interference is a potent tool for downregulating MyD88 expression in myeloid dendritic cells.
- Inhibiting MyD88 expression effectively suppresses DC maturation and associated immune activation.
- This approach presents a promising new strategy for gene therapy in diseases involving aberrant DC function.
Related Concept Videos
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...